High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires

被引:247
作者
Haroon, Muhammad [1 ]
Kirby, Brian [2 ]
FitzGerald, Oliver [1 ]
机构
[1] St Vincents Univ Hosp, Dept Rheumatol, Dublin 4, Ireland
[2] St Vincents Univ Hosp, Dept Dermatol, Dublin 4, Ireland
关键词
EPIDEMIOLOGY; TOOL;
D O I
10.1136/annrheumdis-2012-201706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The objectives of this study were to: (1) assess the prevalence of psoriatic arthritis (PsA) among Psoriasis (Ps) patients attending dermatology clinics; (2) identify clinical predictors of the development of PsA; and (3) compare the performance of three PsA screening questionnaires: Psoriatic Arthritis Screening and Evaluation (PASE), Psoriasis Epidemiology Screening Tool (PEST) and Toronto Psoriatic Arthritis Screening (ToPAS). Methods Patients were divided into two groups: Group-1, consecutive psoriasis patients attending dermatology clinics with no known diagnosis of inflammatory arthritis and Group-2, consecutive patients attending rheumatology clinics with a confirmed diagnosis of PsA. In Group-1, patients completed the screening questionnaires, followed by a full rheumatological evaluation whether or not they reported musculoskeletal symptoms. Results 200 patients were recruited with 100 in each group. In all, 84% of patients in dermatology group were using systemic therapy for their skin disease, and 99% of patients in rheumatology group were on systemic immunosuppressives. In Group-1, 29% of patients were diagnosed with PsA after rheumatological evaluation. On univariate and multivariate analyses, there was a significant positive association between Psoriasis Area and Severity Index and a new diagnosis of PsA (p=0.046). Different patterns of joint involvement were noted in patients with newly diagnosed PsA versus patients with established PsA with fewer polyarticular disease presentations (p=0.0001). In Group-1, the PEST, PASE and ToPAS assessments had sensitivities of 27.5%, 24% and 41%, and specificities of 98%, 94% and 90%, respectively. In Group-2, the sensitivities were 86%, 62% and 83%, respectively. Conclusions 29% of Ps patients attending dermatology clinics had undiagnosed PsA. Psoriasis severity was associated with a new diagnosis of PsA. Poor sensitivities for the screening questionnaires were noted due to inadequate detection of patterns of arthritis other than polyarticular disease.
引用
收藏
页码:736 / 740
页数:5
相关论文
共 17 条
[1]  
Ash Z, 2011, ANN RHEUM DIS
[2]   Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire [J].
Dominguez, Patrick Lee ;
Husni, M. Elaine ;
Holt, Elizabeth W. ;
Tyler, Stephanie ;
Qureshi, Abrar A. .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (08) :573-579
[3]   Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS) [J].
Gladman, D. D. ;
Schentag, C. T. ;
Tom, B. D. M. ;
Chandran, V. ;
Brockbank, J. ;
Rosen, C. ;
Farewell, V. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) :497-501
[4]   Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? [J].
Gladman, Dafna D. ;
Thavaneswaran, Arane ;
Chandran, Vinod ;
Cook, Richard J. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (12) :2152-2154
[5]  
Gladman DD, 2010, PSORIASIS AND PSORIATIC ARTHRITIS: AN INTEGRATED APPROACH, P57
[6]  
GLADMAN DD, 1987, Q J MED, V62, P127
[7]   The PASE questionnaire: Pilot-testing a psoriatic arthritis screening and evaluation tool [J].
Husni, M. Elaine ;
Meyer, Kathryn H. ;
Cohen, Darel S. ;
Mody, Elinor ;
Qureshi, Abrar A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (04) :581-587
[8]  
Ibrahim GH, 2009, CLIN EXP RHEUMATOL, V27, P469
[9]   A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience [J].
Kane, D ;
Stafford, L ;
Bresnihan, B ;
FitzGerald, O .
RHEUMATOLOGY, 2003, 42 (12) :1460-1468
[10]  
Marshall CL, 2010, RHEUMATOLOGY, V49, pI50